Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
2018 · Nature Communications · 139 citations
https://doi.org/10.1038/s41467-018-06067-7
H
Hsueh‐Ping Chao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
1.7K
Citations
20
h-index
20
i10-index
Hsueh‐Ping Chao is an academic researcher. The author has contributed to research in topics: Cancer Cells and Metastasis & Prostate Cancer Treatment and Research & Cancer Research and Treatments. The author has an h-index of 20, co-authored 49 publications.
ORCID: 0000-0001-9404-4300Papers by this author
worksIntron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer
2020 · Nature Communications · 132 citations
https://doi.org/10.1038/s41467-020-15815-7
Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells
2015 · Oncotarget · 75 citations
https://doi.org/10.18632/oncotarget.4260
NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis
2016 · Cell Discovery · 60 citations
https://doi.org/10.1038/celldisc.2016.41
LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer
2019 · Nature Communications · 36 citations
https://doi.org/10.1038/s41467-019-13532-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat